| The Efficacy and Safety of Degludec Use for Glycemic Control in Critically Ill Patients: A Prospective Interventional Study |
Ongoing |
INSULIN ASPART,INSULIN DEGLUDEC |
3 |
1 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| Assessment of Quality of Life in Patients with Relapsing Multiple Sclerosis treated with Cladribine tablets in the Kingdom of Saudi Arabia |
Ongoing |
Cladribine |
4 |
MS700568-2 |
King Fahad Medical City (Riyadh) |
| Medical treatment for congenital hereditary endothelial dystrophy |
Ongoing |
Nepafenac |
2 |
22071-CT |
King Khaled Eye Specialist Hospital (Riyadh) |
| Randomized, Open-Label, Clinical Trial for Evaluating the Prophylactic Use of Paracetamol for Fasting-induced Headache During the First Week of Ramadan |
Ongoing |
Paracetamol |
3 |
E-22-7145 |
King Khalid University Hospital (Riyadh) |
| Efficacy and safety of cinacalcet in children with secondary hyperparathyroidism due to Vitamin D resistant ricket, two arms, randomized clinical trial (Phase III). |
Ongoing |
MIMPARA 30MG F.C. TABLETS |
3 |
2.1 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| "Comparison of IV ketamine with Standard Analgesia for treatment of vaso occlusive crisis in sickle cell disease." |
Ongoing |
ESKETAMINE HCL |
3 |
2211021 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| "A randomized double-blind placebo-controlled parallel group study assessing the efficacy and safety of dupilumab in patients with Allergic Fungal Rhinosinusitis (AFRS)" |
Ongoing |
Dupilumab |
3 |
EFC16724 |
King Khalid University Hospital (Riyadh) |
| A Phase 2 study of PHE885, B-cell maturation Antigen (BCMA)-directed CAR-T Cells in adult participants with relapsed and refractory multiple myeloma. |
Ongoing |
PHE885 (CAR-T Cell) |
2 |
CPHE885B12201 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| Stress Hydrocortisone in Pediatric Septic Shock (The SHIPSS trial) |
Ongoing |
Hydrocortisone |
4 |
SCT22R/009 |
King Abdulaziz Medical City NG (Riyadh) |
| iOUTRUN: Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients |
Ongoing |
Benralizumab |
4 |
D3250R0011 |
King Fahad Medical City (Riyadh) |
